Weight-Loss Powerhouse Saxenda Among Dozens Of New FDA Guidance Docs
Dozens Of Guidance Documents Published In Agency’s Latest Batch; Follows Wegovy
Generics manufacturers looking to target the popular weight-loss drug Saxenda – a precursor therapy to Novo Nordisk’s wildly successful Wegovy – can look to the US FDA’s latest product specific guidance on developing their own versions of the GLP-1 receptor agonist.
